Advertisement

Advertisement

Direct From ASCO

Issues in Oncology

New Study Shows Difficulty in Identifying Transgender Individuals Using EHR Data

Katherine H. Crawford, MA, PMP  /  June 10, 2021

In order to understand and eliminate disparities in cancer incidence and outcomes among transgender people, clinicians and researchers must have data. However, these data are very difficult to obtain because gender identity data are not routinely collected in oncology practice health records. A new...

Senators Richard Burr and Ben Cardin Recognized as ASCO Congressional Champions for Cancer Care

ASCO  /  June 10, 2021

ASCO has presented Senators Richard Burr (R-NC) and Ben Cardin (D-MD) with the annual Congressional Champion for Cancer Care Award in recognition of their ongoing commitment to legislation that improves the environment for cancer research, oncology practice, and the quality of care for patients. The...

Telehealth Flexibilities Helping People Have Uninterrupted Access to Cancer Care Should Continue After the COVID-19 Pandemic

ASCO  /  June 10, 2021

ASCO submitted comments to a House Ways and Means Health Subcommittee hearing titled “Charting the Path Forward for Telehealth.” The comments convey ASCO’s views on how telehealth can better serve individuals with cancer and the oncology professionals who care for them. During the COVID-19 pandemic...

ASCO Board of Directors and Nominating Committee

The ASCO Post Staff  /  June 3, 2021 - Narratives Special Issue

ASCO has elected five new members to the ASCO Board of Directors and the Nominating Committee for 4- and 3-year terms, respectively, starting in June 2021: Gladys I. Rodriguez, MD, has been elected to a Designated Community Oncologist seat on the Board. Dr. Rodriguez is Vice President of ...

ASCO Issues Guideline on Dyspnea in Advanced Cancer

LEAH LAWRENCE  /  May 25, 2021

ASCO has issued a new guideline on the clinical management of dyspnea in adult patients with advanced cancer.1 Dyspnea—or breathlessness—is a common and distressing symptom affecting upward of 70% of patients with advanced cancer.2 “Dyspnea is a highly prevalent symptom, particularly when people wi...

ASCO Honors 2021 Special Awards Recipients

ASCO  /  May 25, 2021

Researchers, patient advocates, and global oncology leaders who have worked to reshape cancer care around the world are among the recipients of ASCO’s Special Awards—the Society’s highest honors—and the Women Who Conquer Cancer Mentorship Awards from Conquer Cancer, the ASCO Foundation. “The recipi...

Lung Cancer
Genomics/Genetics

ASCO and Ontario Health Publish Joint Update on Guideline for Targeted Therapy in NSCLC With Driver Alterations

Brandon May  /  May 10, 2021

ASCO and Ontario Health (Cancer Care Ontario) have jointly published an update1 to the 2017 ASCO guideline2 regarding systemic therapy recommendations for stage IV non–small cell lung cancer (NSCLC) with driver alterations. Guideline Co-Chair Nasser H. Hanna, MD, of the Indiana University Simon Comp...

Fostering a Global Community of Early-Career Oncologists, Virtually

Katherine H. Crawford, MA, PMP  /  May 10, 2021

In a typical year, the new participants in ASCO and Conquer Cancer’s International Development and Education Awards (IDEA) and International Development and Education Awards–Palliative Care (IDEA-PC) program would arrive at the McCormick Place Convention Center just ahead of the ASCO Annual Meeting....

ASCO Answers Guide: Cancer Survivorship

ASCO  /  May 10, 2021

As patients finish active treatment, they often wonder: “What happens next?” ASCO Answers: Cancer Survivorship assists in answering this often-difficult question by helping patients better understand survivorship, including its psychological, physical, sexual, reproductive, financial, and work-relat...

New Savings on HealthCare.gov Follow COVID Relief Package

ASCO  /  May 10, 2021

As of April 1, additional savings may be available for new and current consumers who purchase health insurance on HealthCare.gov following passage of the American Rescue Plan. The Centers for Medicare & Medicaid Services (CMS) also extended access to the Special Enrollment Period (SEP) for the f...

Breast Cancer

New ASCO Guideline Offers Recommendations for Neoadjuvant Breast Cancer Treatment

BRANDON MAY  /  April 25, 2021

ASCO has released a new guideline regarding the use of neoadjuvant chemotherapy, endocrine therapy, and targeted therapy in breast cancer.1 “This is the first time ASCO has embarked on a guideline for neoadjuvant therapy,” said Larissa A. Korde, MD, of the National Cancer Institute, and guideline Co...

Global Cancer Care
Gynecologic Cancers

Increasing Cervical Cancer Prevention and Care in Nepal

Katherine H. Crawford, MA, PMP  /  April 25, 2021

A new JCO Global Oncology special article details the process and results of a Multidisciplinary Cervical Cancer Prevention Course that ASCO volunteers led in Nepal, where cervical cancer remains the most common cancer among women and most patients present with an advanced stage of the disease.1 Th...

Addressing Oncologist Burnout, Emotional Well-Being, and Moral Distress in the Pandemic

ASCO  /  April 25, 2021

JCO Oncology Practice recently published an editorial that examines the intensified burnout oncology practitioners are experiencing due the COVID-19 pandemic and outlines critical interventions to support oncologists now and throughout a long-term recovery.1 The article was written by past, current,...

Breast Cancer

Improvement Programs to Optimize Patient Care for Black Americans With Breast Cancer

ASCO  /  April 25, 2021

Eight oncology practices in eight different U.S. metropolitan areas with high rates of breast cancer disparities between Black and White Americans have been selected to participate in ASCO’s quality programs, including the Quality Oncology Practice Initiative (QOPI®)and Quality Training Program (QTP...

Knuckles

Kathryn E. Hitchcock, MD, PhD  /  April 10, 2021

The swastikas on his knuckles kept stealing my attention. I tried not to stare but every time he gestured to emphasize his words my gaze snapped back there. That awful symbol, multiplied across all 10 digits, refused to be ignored. The blue lines were blurred and misshapen, probably jail tats. I gre...

Legislation Aims to Increase HPV Vaccine Awareness, Access, and Research

ASCO  /  April 10, 2021

ASCO has endorsed the “PREVENT HPV Cancers Act” (H.R. 1550), which was recently introduced by Representative Kathy Castor (FL-14). In a recent letter to the lawmaker, ASCO thanked Rep. Castor for introducing this important measure to increase research on, awareness of, and access to the vaccine, whi...

Executive Order Aims to Secure Access to Essential Pharmaceuticals by Strengthening Supply Chains

ASCO  /  April 10, 2021

President Biden signed an Executive Order calling for a 100-day review of the United States’ pharmaceutical supply chains in an effort to create more resilient and secure access to essential pharmaceuticals while reducing overreliance on foreign competitors. This Executive Order is driven largely by...

Oncology Clinician Well-Being Roadmap Provides 5-Year Plan to Address Provider Burnout

ASCO  /  April 10, 2021

ASCO recently released the ASCO Oncology Clinician Well-Being Task Force Roadmap. The document outlines a 5-year plan to improve the quality of cancer care by enhancing the well-being of oncology clinicians and sustainability of oncology practices. The roadmap’s specific goals include promoting cli...

Lung Cancer

ASCO Publishes Guideline Endorsement of ASTRO Guideline for Radiation Therapy in SCLC

ASCO  /  March 25, 2021

An ASCO Expert Panel has endorsed an American Society for Radiation Oncology (ASTRO) guideline on radiation therapy for small cell lung cancer (SCLC), stating the recommendations in the ASTRO guideline “are clear, thorough, and based upon the most relevant scientific evidence” available.1 Radiothe...

Health-Care Policy Expert Sybil R. Green, JD, RPh, MHA, Brings Wealth of Experience as ASCO’s First Diversity and Inclusion Officer

ASCO  /  March 25, 2021

Sybil R. Green, JD, RPh, MHA, has been named Diversity and Inclusion Officer by ASCO. A health-care policy expert with experience in both corporate and nonprofit organizations, Ms. Green will guide ASCO’s internal and external initiatives aimed at achieving the Society’s equity, diversity, and inc...

Oncology Clinician Well-Being Roadmap Provides 5-Year Plan to Address Provider Burnout

ASCO  /  March 25, 2021

ASCO recently released the ASCO Oncology Clinician Well-Being Task Force Roadmap. The document outlines a 5-year plan to improve the quality of cancer care by enhancing the well-being of oncology clinicians and sustainability of oncology practices. The roadmap’s specific goals include promoting cli...

Actions Early in Biden Administration Mirror ASCO Road to Recovery Report

ASCO  /  March 25, 2021

ASCO’s Road to Recovery Report: Learning from the COVID-19 Experience to Improve Clinical Research and Cancer Care, among other recommendations, calls for the U.S. Department of Health and Human Services (HHS) to establish a special enrollment period on the federal health insurance exchange, abandon...

Eleven Oncology Practices Receive Quality Certification From the Association for Clinical Oncology

ASCO  /  March 25, 2021

The Association for Clinical Oncology congratulates the 11 practices that prioritized the quality of care they provide by achieving the Quality Oncology Practice Initiative (QOPI®) Certification in the second half of 2020. These practices have shown that they are committed to providing the highest-...

ASCO and Friends of Cancer Research Recommend Expanding Patient Access to Cancer Clinical Trials by Further Broadening Eligibility Criteria

ASCO  /  March 10, 2021

ASCO and Friends of Cancer Research (Friends) jointly issued new recommendations to further efforts to broaden eligibility criteria in cancer clinical trials with the goal of making clinical trials more accessible to patients.1 The joint recommendations are detailed in a series of articles published...

New Research Statement Recommends Streamlining and Standardizing Clinical Trial Site Feasibility Assessments

ASCO  /  March 10, 2021

Feasibility assessments for clinical trials are conducted to establish that prospective trial sites can safely and effectively meet study goals and protocol requirements; however, a new research statement from ASCO asserts that current standards are “costly, inconsistent, inefficient, labor intensiv...

Gastrointestinal Cancer

ASCO Names Advance of the Year: Molecular Profiling Drives Progress in Gastrointestinal Cancers

ASCO  /  February 25, 2021

Molecular profiling allows clinicians to identify the molecular and genetic signatures that help to deliver treatments that are highly specific to a tumor. This tool has made possible a number of advances in the past year that are improving care for patients with gastrointestinal cancers. In recogni...

Issues in Oncology

New Framework to Address Cancer Care Disparities in Medically Underserved Populations

ASCO  /  February 25, 2021

A new article published in JCO Oncology Practice puts forth a framework to guide researchers, health-care leaders, advocates, community- and patient-focused service organizations, and policy leaders in their work to address and promote health equity in cancer care access and treatment outcomes.1 Th...

Standardized, Streamlined Processes Key to Implementing Electronic Prior Authorization

ASCO  /  February 25, 2021

On December 23, 2020, ASCO submitted comments to the Centers for Medicare & Medicaid Services (CMS) in response to the Reducing Provider and Patient Burden and Promoting Patients’ Electronic Access to Health Information proposed rule. This rule builds on the CMS Interoperability and Patient Acce...

Medicare Physician Fee Schedule Conversion Factor Updated to Reflect 2021 Federal Funding Package

ASCO  /  February 25, 2021

The Centers for Medicare & Medicaid Services (CMS) announced a revised Medicare Physician Fee Schedule conversion factor of $34.8931 for 2021. This represents a 3.3% reduction from the 2020 conversion factor of $36.0869. CMS updated the conversion factor as a result of a provision in the $1.4 tr...

Biden Administration, New Congress Review Recent Rules Affecting Cancer Care Delivery

ASCO  /  February 25, 2021

In the days and weeks leading up to President Biden’s inauguration, the Department of Health and Human Services (HHS)—under the prior administration—issued a number of rules and regulations that affect cancer care delivery. Many of those rules and regulations are now subject to review by the new adm...

Sean Khozin, MD, MPH, Named New Chief Executive Officer of ASCO’s CancerLinQ

The ASCO Post Staff  /  February 10, 2021

Sean Khozin, MD, MPH, has been named Chief Executive Officer of CancerLinQ LLC, a wholly owned nonprofit subsidiary of ASCO. A board-certified oncologist, physician-scientist, and data science expert, Dr. Khozin is a proven leader and visionary in deploying cutting-edge data science and technology s...

ASCO Congratulates Joseph R. Biden, Jr, on Presidential Inauguration

ASCO  /  February 10, 2021

“On the eve of his inauguration, the Association for Clinical Oncology (ASCO) congratulates ­Joseph R. Biden, Jr, the 46th President of the ­United States. “ASCO shares the President’s commitment to ensuring equitable high-quality cancer care for every American, and recently released a policy state...

ASCO Advocates for Priority Status for Patients With Cancer in COVID-19 Vaccine Distribution Plans, Provides Information on Safety and Efficacy of Vaccinations

ASCO  /  February 10, 2021

The American Society of Clinical Oncology and the Association for Clinical Oncology, collectively referred to as ASCO, understand the challenges faced by ASCO members and patients with cancer in dealing with the COVID-19 pandemic, in determining the best treatment for patients, and in addressing que...

Dr. Eric P. Winer Elected ASCO President for 2022–2023 Term

ASCO  /  January 25, 2021

ASCO has elected Eric P. Winer, MD, FASCO, a long-time member and volunteer, to serve as President for the term beginning in June 2022. He will take office as President-Elect during the ASCO Annual Meeting in June 2021. Five new members were also elected to the ASCO Board of Directors and the Nomina...

Conquer Cancer Announces 2020 Career Development Award in Breast Cancer Recipient

ASCO  /  January 25, 2021

Conquer Cancer, the ASCO Foundation, is pleased to announce Clinton Yam, MD, as the recipient of the 2020 Fairman Career Development Award (CDA). Dr. Yam’s research will focus on identifying novel immune markers to predict response to treatment and identifying if tumor response is influenced by gut ...

ASCO Applauds Congress for Expanding Clinical Trial Access for Medicaid Beneficiaries

ASCO  /  January 25, 2021

Statement By Monica M. Bertagnolli, MD, FACS, FASCO, Chair of ASCO “Congress took a giant step forward to reduce health disparities by expanding clinical trial access to more than 41.6 million Medicaid beneficiaries through passage of the bipartisan CLINICAL TREATMENT Act as part of its end-of-yea...

Continuing Education Credits for Gastrointestinal Cancers Symposium

ASCO  /  January 25, 2021

In support of improving patient care, ASCO is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health-care tea...

Clinician Scientist Hopes to Attract New Investigators in Gynecologic Cancer by Establishing Conquer Cancer Award

ASCO  /  January 25, 2021

Stephen A. Cannistra, MD, FASCO, was among the first scientists to define the mechanisms by which ovarian cancer cells spread throughout the peritoneal cavity. His work further defined the role of apoptosis in mediating chemotherapy-induced killing of ovarian cancer cells, as well as the possibility...

Increase Your Knowledge and Practice of Cultural Competence With ASCO eLearning Course Collection

ASCO  /  December 25, 2020

“Equity: Every Patient. Every Day. Everywhere” was selected by 2020–2021 ASCO President Lori J. Pierce, MD, FASTRO, FASCO, as the theme for her presidential term. As oncology care providers work to put this theme into practice, they can find support in ASCO eLearning’s new Cultural Literacy course c...

The Heart of Catherine Handy Marshall, MD, MPH’s Work

ASCO  /  December 25, 2020

In 2017, Women Who Conquer Cancer (WWCC) awarded Catherine Handy Marshall, MD, MPH, a Conquer Cancer Young Investigator Award (YIA) grant to explore the impact of cardiovascular disease risk factors on cancer outcomes. Three years after receiving the WWCC YIA, Dr. Handy Marshall is pursuing addition...

ASCO’s Oncologist-Approved Patient Information Website: Cancer.Net

ASCO  /  December 25, 2020

What makes Cancer.Net one of the most trustworthy websites for patients with cancer? ASCO’s expertise. All content on Cancer.Net is approved by an editorial board composed of more than 150 oncologists, oncology nurses, physician assistants, social workers, and patient advocates. Oncologists refer ...

CMS Increases Access to Telemedicine in Home Health Care

ASCO  /  December 25, 2020

The Centers for Medicare & Medicaid Services (CMS) recently released its Home Health Prospective Payment System final rule for 2021. The final rule reflects comments ASCO submitted on the proposed rule in support of increased access to telemedicine in home health care and concerns over home infu...

New Recommendations for Advancing the Scholarly Discipline of Global Oncology

ASCO  /  December 25, 2020

New recommendations aimed at advancing the status of global oncology as an academic discipline were published in November as a special article in JCO Global Oncology.1 The field of global oncology is important. According to the World Health Organization,2 cancer is the second-leading cause of death...

Career Development Award Winner Dr. Aparna Parikh on the Emerging Importance of Liquid Biopsies for GI Cancers

ASCO  /  December 10, 2020

Systematic liquid biopsies are transforming treatment approaches for patients with gastrointestinal (GI) cancers. Many GI tumors are detected late, which ultimately reduces 5-year overall survival rates. Liquid biopsies may become increasingly important both in the early detection and treatment spac...

New ASCO Series for Early-Career Cancer Providers on Impacts of Social Determinants of Health

ASCO  /  December 10, 2020

As part of its ongoing commitment to addressing inequities in cancer care and research, ASCO has launched a new educational series focused on the role of social determinants of health in cancer care and cancer outcomes. The free series, which began October 21, is aimed at educating oncology trainees...

Save 20% When You Stock Your Practice With ASCO Answers Materials for 2021

ASCO  /  December 10, 2020

ASCO has helpful, trusted resources to support your patients and their caregivers. Available in three convenient formats, you can choose from fact sheets; topic-specific booklets; and comprehensive, patient-friendly guides. ASCO Answers materials provide trusted, easy-to-understand information abo...

New Rules on Health-Care Price Transparency and Coverage for COVID-19 Vaccines

ASCO  /  December 10, 2020

ON OCTOBER 28, the U.S. Department of Health and Human Services (HHS), the U.S. Department of Labor, and the U.S. Department of the Treasury released the coverage transparency final rule. Building on earlier administration actions requiring hospitals to disclose standard charges and negotiated rates...

Job Loss During Cancer: How to Cope and Continue Treatment

ASCO  /  November 25, 2020

Job loss is stressful no matter the circumstances. Recently, millions of people have lost their jobs during the COVID-19 pandemic. To make matters more difficult, job loss in the United States can often mean a loss of health insurance. For people with cancer, losing a job is especially challenging b...

Issues in Oncology

Gateway for Cancer Research and Conquer Cancer Offer Grant Funding to Research Health Disparities

ASCO  /  November 25, 2020

Gateway for Cancer Research® is investing $1.5 million to ensure that a more diverse patient population is represented in oncology research and to expand clinical trial access for patients from underserved and underrepresented communities. The second biennial Gateway Discovery Grant, administered b...

Time Is Running Out: Prepare for 2021 E&M Changes Today

ASCO  /  November 25, 2020

Significant changes are coming to the office and outpatient Evaluation and Management (E&M) services Current Procedural Terminology (CPT®) codes (99202-99215). Practices, physicians, and staff who have not done so already must begin preparing for these changes today to ensure a successful transi...

Advertisement

Advertisement



Advertisement